TrialThe American journal of gastroenterology2016

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.

Stephan R Targan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.